康华生物 (300841.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(康华生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年三季报2024年中报2024年一季报2023年年报2023年三季报2023年中报2023年一季报
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 1,060,378,720.25741,084,779.28311,367,042.841,577,395,401.05990,055,021.87634,439,056.46278,114,028.88
 营业收入(元) 1,060,378,720.25741,084,779.28311,367,042.841,577,395,401.05990,055,021.87634,439,056.46278,114,028.88
二、营业总成本(元) 577,201,604.21365,393,381.89134,855,630.79959,259,718.87586,246,100.92363,213,245.23166,597,332.57
 营业成本(元) 60,754,419.4540,452,790.8112,932,420.59102,148,838.0563,760,598.9941,120,618.9017,959,359.49
 研发费用(元) 92,407,491.6664,526,823.0525,825,264.01253,025,564.84185,927,273.77105,813,253.7348,657,680.12
 营业税金及附加(元) 6,618,619.595,259,389.941,433,446.399,764,361.475,903,315.604,480,351.981,133,460.40
 销售费用(元) 342,928,667.60207,048,027.5371,894,819.67495,444,122.89270,260,847.60175,106,092.4078,388,151.54
 管理费用(元) 81,125,872.8754,105,759.9624,974,340.19106,823,579.2066,257,126.4140,462,817.6422,181,067.10
 财务费用(元) -6,633,466.96-5,999,409.40-2,204,660.06-7,946,747.58-5,863,061.45-3,769,889.42-1,722,386.08
  其中:利息费用(元) 3,967,174.602,669,150.301,409,120.364,805,740.973,540,734.102,355,781.161,024,731.41
  其中:利息收入(元) 9,079,527.246,943,109.573,457,384.6012,589,388.509,242,597.765,934,283.212,768,389.49
三、其他经营收益
 加:公允价值变动收益(元) -8,007,486.61-4,577,171.60521,701.06-31,597,059.9310,943,588.7715,443,223.9213,053,201.93
 加:投资收益(元) 957,513.83800,421.1991,655.47348,750.00---
 资产处置收益(元) -1,794,548.96---186,829.86---
 资产减值损失(元) -1,428,527.86139,172.7794,418.80-1,630,392.721,293,078.22-465,228.48-183,963.08
 信用减值损失(元) -11,686,415.30-22,072,309.27-5,555,740.26-9,837,646.58-7,275,210.13-10,157,555.88-7,608,956.94
 其他收益(元) 1,433,364.051,432,285.31491,505.361,379,658.57-244,090.602,075,909.40261,009.40
四、营业利润(元) 462,651,015.19351,413,795.79172,154,952.48576,612,161.66408,526,287.21278,122,160.19117,037,987.62
 加:营业外收入(元) 15.85--15,497.4044,069.4415,427.3410,876.92
 减:营业外支出(元) 214,166.91111,458.9810,675.602,634,064.47539,070.42242,028.42159,839.95
五、利润总额(元) 462,436,864.13351,302,336.81172,144,276.88573,993,594.59408,031,286.23277,895,559.11116,889,024.59
 减:所得税费用(元) 56,534,637.6744,747,494.9122,677,282.8964,777,629.8439,093,195.7629,690,676.4911,698,408.06
六、净利润(元) 405,902,226.46306,554,841.90149,466,993.99509,215,964.75368,938,090.47248,204,882.62105,190,616.53
(一)按经营持续性分类
  持续经营净利润(元) 405,902,226.46-149,466,993.99509,215,964.75368,938,090.47-105,190,616.53
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 405,902,226.46306,554,841.90149,466,993.99509,215,964.75368,938,090.47248,204,882.62105,190,616.53
 扣除非经常性损益后的净利润(元) 412,569,507.28308,828,307.56148,536,313.44543,046,767.07360,264,245.37233,506,207.7394,000,155.42
七、每股收益
 一、基本每股收益(元) 3.072.301.123.812.761.860.79
 二、稀释每股收益(元) 3.072.301.123.812.761.860.79
九、综合收益总额(元) 405,902,226.46306,554,841.90149,466,993.99509,215,964.75368,938,090.47248,204,882.62105,190,616.53
 归属于母公司所有者的综合收益总额(元) 405,902,226.46306,554,841.90149,466,993.99509,215,964.75368,938,090.47248,204,882.62105,190,616.53
公告日期 2024-10-292024-08-172024-04-242024-03-302023-10-212023-08-232023-04-25
审计意见(境内) 标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院